Eli Lilly to Expand Vaccine Pipeline With Three Biotech Buyouts
LLY plans $3.83B in biotech buyouts to expand into vaccines and infectious diseases beyond obesity and diabetes.
Open original sourceLoading market dashboard
LLY plans $3.83B in biotech buyouts to expand into vaccines and infectious diseases beyond obesity and diabetes.
Open original source